Scientists Should Spend More Time Communicating With The Public

"If it blows up, it's chemistry. If it dies, it's biology. If it doesn't work, it's physics." These immutable truths seemed to govern classroom science in my high school, and they drove me to become an English major in college. I went reluctantly. As a boy, I had collected insects, fossil seashells, and just about anything from nature that didn't emit foul odors and annoy my mother. But in classrooms, my fascination with the natural world slowly withered as my science teachers recited only th

Written byJohn Wilkes
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

"If it blows up, it's chemistry. If it dies, it's biology. If it doesn't work, it's physics." These immutable truths seemed to govern classroom science in my high school, and they drove me to become an English major in college.

I went reluctantly. As a boy, I had collected insects, fossil seashells, and just about anything from nature that didn't emit foul odors and annoy my mother.

But in classrooms, my fascination with the natural world slowly withered as my science teachers recited only the bare facts - units of neatly packaged knowledge, purged of any of the agonizing and exhilarating detective work that produced it. And I couldn't seem to do the canned experiments or dissections right. Disappointed and bored, I knew by age 16 that whatever I did in life, it would be as far from laboratory science as I could get.

Ironically, after going all the way ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies